The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of preoperative chemoradiotherapy (CRT) on the rectal tumor microenvironment (TME) and associated patient outcomes.
 
Mohamed E. Salem
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Taiho Pharmaceutical
Speakers' Bureau - Genentech/Roche; Taiho Pharmaceutical
 
Hsih-Te Yang
No Relationships to Disclose
 
Wei Sha
No Relationships to Disclose
 
James Thomas Symanowski
Consulting or Advisory Role - CARsgen Therapeutics; Endocyte (Inst); Immatics; Lilly
 
Alberto Puccini
No Relationships to Disclose
 
Jimmy J. Hwang
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Centers of Excellence; Deciphera; Incyte; Pfizer; QED Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Deciphera; Incyte
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst)
 
Kunal C. Kadakia
No Relationships to Disclose
 
Laura W. Musselwhite
No Relationships to Disclose
 
Edward S. Kim
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Merck; Pfizer; Roche/Genentech; Takeda
Research Funding - Boehringer Ingelheim; Genentech/Roche; Ignyta; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Genentech/Roche; Merck; Pfizer; Takeda
 
Thomas J. George
Consulting or Advisory Role - Pfizer; Tempus
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Seagen (Inst)
 
David Foureau
No Relationships to Disclose